The e-commerce API provider plans to use the proceeds from the Rewe Group-backed round to expand internationally.

The online food retail platform took in series E capital from investors including Japan Post Capital at a pre-money valuation topping $1bn.

Cornell spinout Lexeo Therapeutics has added $100m to its coffers thanks to a series B round co-led by D1 Capital Partners and Eventide Asset Management.

The mobile game developer secured $350m from investors including Netmarble and Kabam and has closed the purchase of gaming studio Ludia.

Tencent was among the investors in a round which valued the automotive e-commerce platform developer at $1.75bn.

Access Industries and Workday Ventures contributed to a series D round which more than tripled the workforce management platform developer's valuation to $3.7bn.

Softbank, Foxconn and Xiaomi all backed a series C round for the smart robotics technology developer, which is now valued at over $1bn.

Amgen, Bristol Myers Briggs and Vertex Pharmaceuticals were among the investors that brought the gene therapy developer’s overall funding to over $164m.

The gene therapy developer secured backing from Lundbeck and Alexandria Real Estate Equities in a series B round that will support the advancement of its clinical pipeline.

Disease diagnostics technology developer Mammoth Biosciences is valued at over $1bn following funding rounds backed by investors including Amazon.